FDA NDC Directory · JSON-LD · Markdown

OLANZAPINE

NDC 68462-952 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerGLENMARK PHARMACEUTICALS INC., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA220323
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR
Active ingredientsOLANZAPINE (10 mg/2mL)
Marketing started20260305
Package count1

External sources

Source: openFDA. Public-domain (CC0).